eBay
EBAY
Halozyme Therapeutics
HALO
Lantheus
LNTH
Teradata Corp
TDC
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
AUR Aurora Innovation
- 7.170
- +0.010+0.14%
Trading Dec 19 10:01 ET
12.32BMarket Cap-15.26P/E (TTM)
7.385High7.125Low902.47KVolume7.350Open7.160Pre Close6.54MTurnover0.09%Turnover RatioLossP/E (Static)1.72BShares8.44052wk High6.11P/B6.91BFloat Cap2.10052wk Low--Dividend TTM964.10MShs Float11.780Historical High--Div YieldTTM3.63%Amplitude1.100Historical Low7.246Avg Price1Lot Size
Aurora Innovation Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.72%-143M | 3.30%-176M | -10.29%-150M | -17.72%-598M | 5.67%-133M | -3.52%-147M | -104.49%-182M | 0.00%-136M | 9.93%-508M | 1.50%-141M |
| Net income from continuing operations | -9.47%-208M | 16.51%-182M | 15.82%-165M | 53.80%-796M | 34.69%-192M | 4.04%-190M | 81.11%-218M | -154.55%-196M | -128.21%-1.72B | -17.03%-294M |
| Operating gains losses | 660.00%28M | -110.00%-1M | -700.00%-12M | 117.54%20M | 218.18%13M | -266.67%-5M | 125.00%10M | 103.03%2M | -507.14%-114M | -154.65%-11M |
| Depreciation and amortization | -20.00%4M | 20.00%6M | 0.00%5M | -4.55%21M | 20.00%6M | -16.67%5M | 0.00%5M | -16.67%5M | 37.50%22M | -3.18%5M |
| Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cash items | 16.67%7M | -14.29%6M | 0.00%7M | 8.00%27M | 133.33%7M | -14.29%6M | -12.50%7M | 0.00%7M | -32.43%25M | -73.27%3M |
| Change In working capital | -200.00%-2M | -68.18%-37M | -192.86%-13M | -116.67%-2M | 300.00%4M | -50.00%2M | -148.89%-22M | 140.00%14M | 111.43%12M | 92.77%-2M |
| -Change in other current assets | ---8M | -133.33%-2M | -500.00%-8M | -97.87%1M | -75.00%-7M | --0 | -81.82%6M | -87.50%2M | 197.92%47M | 91.48%-4M |
| -Change in other current liabilities | 200.00%6M | -25.00%-35M | -141.67%-5M | 91.43%-3M | 450.00%11M | 0.00%2M | -333.33%-28M | 123.53%12M | 38.60%-35M | 104.97%2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.72%-143M | 3.30%-176M | -10.29%-150M | -17.72%-598M | 5.67%-133M | -3.52%-147M | -104.49%-182M | 0.00%-136M | 9.93%-508M | 1.50%-141M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -548.08%-466M | -31.03%120M | 87.04%101M | 100.94%8M | -276.74%-324M | 36.84%104M | 34.88%174M | 105.56%54M | -440.80%-852M | -598.56%-86M |
| Net PPE purchase and sale | -40.00%-7M | -175.00%-11M | -300.00%-8M | 0.00%-15M | -33.33%-4M | -66.67%-5M | 0.00%-4M | 60.00%-2M | 68.75%-15M | 81.10%-3M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | -521.10%-459M | -26.40%131M | 94.64%109M | 102.75%23M | -285.54%-320M | 37.97%109M | 33.83%178M | 105.80%56M | ---837M | ---83M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -548.08%-466M | -31.03%120M | 87.04%101M | 100.94%8M | -276.74%-324M | 36.84%104M | 34.88%174M | 105.56%54M | -440.80%-852M | -598.56%-86M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -43.63%469M | 180.00%4M | 2M | 7,454.55%831M | 300.00%4M | 27,633.33%832M | -200.00%-5M | 0 | -99.29%11M | -99.91%1M |
| Net common stock issuance | -43.58%470M | 400.00%5M | 200.00%3M | 6,361.54%840M | 400.00%5M | 27,666.67%833M | -85.71%1M | -50.00%1M | 62.50%13M | -69.61%1M |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | 0.00%-1M | 83.33%-1M | 0.00%-1M | -350.00%-9M | ---1M | ---1M | ---6M | ---1M | -100.18%-2M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -43.63%469M | 180.00%4M | --2M | 7,454.55%831M | 300.00%4M | 27,633.33%832M | -200.00%-5M | --0 | -99.29%11M | -99.91%1M |
| Net cash flow | ||||||||||
| Beginning cash position | 130.22%419M | 141.54%471M | 87.00%518M | -82.96%277M | 93.04%971M | -67.84%182M | -62.57%195M | -82.96%277M | 306.50%1.63B | -21.88%503M |
| Current changes in cash | -117.74%-140M | -300.00%-52M | 42.68%-47M | 117.87%241M | -100.44%-453M | 1,352.38%789M | -128.89%-13M | 92.58%-82M | -210.03%-1.35B | -123.01%-226M |
| End cash Position | -71.27%279M | 130.22%419M | 141.54%471M | 87.00%518M | 87.00%518M | 93.04%971M | -67.84%182M | -62.57%195M | -82.96%277M | -82.96%277M |
| Free cash flow | 1.32%-150M | -0.54%-187M | -14.49%-158M | -17.21%-613M | 4.86%-137M | -4.83%-152M | -100.00%-186M | 2.13%-138M | 14.54%-523M | 9.44%-144M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |